| 000 | 00000cam 2200000zi 4500 |
| 001 | 9.962156 |
| 003 | CaOODSP |
| 005 | 20260429132329 |
| 006 | m o d f |
| 007 | cr mn||||||||| |
| 008 | 260423e20260420onc ob f000 0 eng d |
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
| 043 | |an-cn--- |
| 086 | 1 |aH113-9/2026-7E-PDF |
| 245 | 00|aAQUABAC II XT Biological Larvicide, containing Bacillus thuringiensis subsp. Israelensis serotype H14, strain BMP-144. |
| 264 | 1|aOttawa, Ontario : |bPesticides Regulatory Directorate, Healthy Environments and Consumer Safety Branch, Health Canada, |c20 April 2026. |
| 264 | 4|c©2026 |
| 300 | |a1 online resource (14 pages). |
| 336 | |atext|btxt|2rdacontent |
| 337 | |acomputer|bc|2rdamedia |
| 338 | |aonline resource|bcr|2rdacarrier |
| 490 | 1 |aProposed registration decision, |x1925-0886 ; |vPRD2026-07 |
| 500 | |aCover title. |
| 500 | |aSummary issued also in HTML format. |
| 500 | |aIssued also in French under title: AQUABAC II XT Larvicide Biologique, contenant la souche BMP-144 de Bacillus thuringiensis subsp. israelensis sérotype H-14. |
| 504 | |aIncludes bibliographical references (page 14). |
| 520 | |a"Health Canada, pursuant to subsection 28(1) of the Pest Control Products Act, is proposing registration for the sale and use of AQUABAC II XT Biological Larvicide, containing Bacillus thuringiensis subsp. israelensis serotype H-14, strain BMP-144, to control fungus gnats on greenhouse ornamentals (use-site category 6 - Greenhouse Non-Food). This evaluation was completed under the User Requested Minor Use Label Expansion program, which is a cooperative program between Agriculture and Agri-Food Canada and Health Canada and includes participation by sponsor groups, manufacturers, and both provincial and federal governments"--Overview, page 1. |
| 650 | 0|aInsecticides|xCertification|zCanada. |
| 650 | 0|aInsecticides|xToxicology. |
| 650 | 0|aInsecticides|xEnvironmental aspects. |
| 710 | 1 |aCanada. |bHealthy Environments and Consumer Safety Branch, |eissuing body. |
| 775 | 08|tAQUABAC II XT Larvicide Biologique, contenant la souche BMP-144 de Bacillus thuringiensis subsp. israelensis sérotype H-14.|w(CaOODSP)9.962161 |
| 830 | #0|aProposed registration decision,|x1925-0886 ; |vPRD2026-07.|w(CaOODSP)9.504464 |
| 856 | 40|qPDF|s565 KB|uhttps://publications.gc.ca/collections/collection_2026/sc-hc/h113-9/H113-9-2026-7-eng.pdf|zReport |
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/consumer-product-safety/pesticides-pest-management/public/consultations/proposed-registration-decisions/2026/aquabac-ii-xt-biological-larvicide-containing-bacillus-thuringiensis-subsp-israelensis-serotype-h-14-strain-bmp-144/document.html|zSummary |